Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26FT082
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,162
Award facts
- Contract value 100% obligated
- $32,162.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,162.38 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The contract, awarded on October 20, 2025, with an ultimate completion date of October 21, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive global pharmaceutical support vehicle valued through December 2026 that enables the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards predominantly with the DLA Medical Supply Chain, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The award of Enbrel, a specialty pharmaceutical used in immunological treatments, reflects AmerisourceBergen's demonstrated capability to fulfill federal medical supply requirements through open competition and aligns with the DLA's strategic approach to ensuring pharmaceutical availability for Defense Health Agency customers, the U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FT082?
SPE2DR26FT082 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DR26FT082 worth?
The government has obligated $32,162 on SPE2DR26FT082.
Is contract SPE2DR26FT082 an order under another contract?
Yes. SPE2DR26FT082 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT082 competed?
The extent of competition for SPE2DR26FT082 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award